BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 18407812)

  • 1. Time, change and peptic ulcer disease in Rotherham, UK.
    Bardhan KD; Royston C
    Dig Liver Dis; 2008 Jul; 40(7):540-6. PubMed ID: 18407812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Admission rates for peptic ulcer in the trent region, UK, 1972--2000. changing pattern, a changing disease?
    Bardhan KD; Williamson M; Royston C; Lyon C
    Dig Liver Dis; 2004 Sep; 36(9):577-88. PubMed ID: 15460842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of surgery in the therapy of peptic ulcer after arrival of H2-blocking drugs].
    Perri S; Amendolara M; Breda E; Todarello V; Gallo G; Pietrangeli F; Meneghini G; Gelmi GF
    G Chir; 1990 Sep; 11(9):466-70. PubMed ID: 1981139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes in ulcer surgery following introduction of H2-blockers].
    Paimela H; Kivilaakso E; Tuompo P; Peräkylä T; Höckerstedt K; Saarlo I
    Nord Med; 1991; 106(6-7):198-201. PubMed ID: 1677178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Surgical therapy of the peptic ulcer in a hospital specializing in gastroenterology. Effects of therapy with h2 antagonists].
    Lorusso D; Pezzolla F; Lantone G; Misciagna G; Guerra V
    Minerva Chir; 1997 Nov; 52(11):1293-7. PubMed ID: 9489325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Peptic ulcer: current therapy].
    Pieragnoli E
    G Clin Med; 1987 Apr; 68(4):197-209. PubMed ID: 2886387
    [No Abstract]   [Full Text] [Related]  

  • 7. Recent trends in admissions and mortality due to peptic ulcer in England: increasing frequency of haemorrhage among older subjects.
    Higham J; Kang JY; Majeed A
    Gut; 2002 Apr; 50(4):460-4. PubMed ID: 11889062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
    Florent C
    Clin Ther; 1993; 15 Suppl B():14-21. PubMed ID: 7911399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The medical therapy of peptic ulcer. The state of the art].
    Perroni GB; De Matteis G; Pellizzeri F; Cassone A; Malara F
    Minerva Chir; 1992 Apr; 47(7):607-12. PubMed ID: 1350332
    [No Abstract]   [Full Text] [Related]  

  • 10. Peptic ulcer perforation before and after the introduction of H2-receptor blockers and proton pump inhibitors.
    Hermansson M; Staël von Holstein C; Zilling T
    Scand J Gastroenterol; 1997 Jun; 32(6):523-9. PubMed ID: 9200281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ulcer surgery and anti-ulcer agents. Changes in surgical activities and sale of anti-ulcer agents in Nord-Trøndelag 1975-89].
    Haaverstad R; Moen OO; Kannelønning KS; Line PD; Wibe A; Bjerkeset T
    Tidsskr Nor Laegeforen; 1994 Mar; 114(8):904-7. PubMed ID: 7910707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drugs for peptic ulcer.
    Clark CG; Wyllie JH
    World J Surg; 1977 Jan; 1(1):3-7. PubMed ID: 17229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drugs for treatment of peptic ulcers.
    Dajani EZ; Trotman BW
    J Assoc Acad Minor Phys; 1992; 3(3):78-88. PubMed ID: 1353999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of H2-receptor antagonists on the complications, morbidity and mortality of peptic ulcer disease.
    Isenberg JI
    Aliment Pharmacol Ther; 1987; 1 Suppl 1():447S-454S. PubMed ID: 2908766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changing pattern of admissions and operations for duodenal ulcer.
    Bardhan KD; Cust G; Hinchliffe RF; Williamson FM; Lyon C; Bose K
    Br J Surg; 1989 Mar; 76(3):230-6. PubMed ID: 2566355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duodenal ulcer and gastroesophageal reflux disease today: long-term therapy--a sideways glance.
    Bardhan KD
    Yale J Biol Med; 1996; 69(3):211-24. PubMed ID: 9165690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Histamine H2-receptor antagonists as new anti-ulcer agents].
    Takemoto T
    Nihon Rinsho; 1984 Jan; 42(1):103-13. PubMed ID: 6143835
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical, secretory, radiological and endoscopic evolution of patients with gastroduodenal ulcer treated with Ulcosilvanil, as compared with those treated with histamine H2 receptor antagonists].
    Contraşiu P; Calinici V
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1980; 32(4):359-63. PubMed ID: 6113650
    [No Abstract]   [Full Text] [Related]  

  • 19. Eradication treatment for Helicobacter pylori in general practice.
    Fraser AG; Moore L; Berry S; Arroll B
    N Z Med J; 1996 Nov; 109(1033):422-4. PubMed ID: 8941293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omeprazole in acute and long-term treatment of Asian patients with peptic ulcer refractory to H2-antagonists.
    Chelvam P; Wong EC
    J Gastroenterol Hepatol; 1989; 4 Suppl 2():75-81. PubMed ID: 2577478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.